MYDGF and hepatocellular carcinoma: Recently, it has been demonstrated that C19orf10 was over-expressed in hepatocellular carcinoma and could enhance hepatocellular carcinoma (HCC) cell proliferation through Akt/mitogen signaling pathway (11).